Statistics Colloquium
October 11 (Fri) 11 a.m.
Alavi Commons Room, 6625 Everett Tower
Use of Statistical Methodology and Computational Tools to Influence the
Early Development Plan of a Drug
Kimberly Crimin
Director Statistical Scientist
Novartis
As decision making within the pharmaceutical industry moves toward
being more `information-based', statisticians in the pharmaceutical
industry have many opportunities to be active collaborators in all
stages of drug development. Some areas in which statisticians can
have an impact on the development plan of a drug are: ensuring
study designs allow quantification of the desired safety and efficacy
of the target product profile, evaluating the operating characteristics
of decision rules and study designs under various scenarios and
clearly communicating results to non-statisticians.
In this talk
I will provide background on a drug development project in asthma,
and describe some of the development questions of interest in which
quantitative information was provided to the project team to guide
the early development plan of the project. I will conclude this
talk by describing key attributes a successful statistician in the
pharmaceutical industry should possess.
All statistics students are expected to attend.
.
Past colloquiums